Stifel cuts Celcuity stock price target on refined market model
What it means
- What to watch: $CELC had its price target revised — one analyst's number is a data point, not a thesis.
- How the stock is trading: $CELC +2.48% in the latest session.
- Timing: It landed before the opening bell — early risers had it with their coffee, and the next session was the first that could react.
Where the stock stands
$CELC last changed hands at $66.87, +2.48% on the session, 56% below its 52-week high of $151.02 and 25% above its low of $53.54 — in the lower part of the range. Over the year it has ranged 182% from low to high: a very wide band — this one has spent the year on a roller coaster, and big swings are business as usual. These are latest-session quotes, not live prices — the live tape is on the $CELC page.
How much coverage it is getting
Nothing else on $CELC in the last 30 days: this is the only story Wook has filed, so there is no run to measure it against yet. 12 related stories from the same name or desk are listed beside this one.
The bigger picture
In healthcare, the calendar is the catalyst — trial readouts, FDA decisions and pricing rules. One result can move a single drugmaker sharply; a policy change moves the whole aisle. On Wook's supply-chain scanner, Health Care reads calm today — no unusual stress in the filings and disclosures it watches. The scanner equivalent of a quiet night shift.
Coming up
$CELC earnings in 16 days. These were on the calendar before this story and are not caused by it.
What to watch next
For the receipts, the $CELC page has the full chart, the filings and the valuation model these figures come from. Want the facts without the spin? Read how two or three outlets frame the same story — where they agree is the news, where they differ is the angle. Wook AI, above, can pull live figures and run the numbers on request — how far $CELC is from its high, or how this week's coverage compares.
How this analysis was made
Investing.com published it, and Wook filed it under Healthcare & Pharma. It reads bearish at medium severity because of “cut” in the wording, with nothing on the bullish side to offset it. It was matched to $CELC. The publisher gave no preview text, and nothing has been written in to fill the gap.
The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Investing.com published this on August 14, 2026. $CELC has moved -27.32% ($92.00 to $66.86). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.